How should I manage a 68-year-old woman with major depressive disorder on escitalopram (Lexapro) 10 mg who is now experiencing hallucinations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hallucinations in a 68-Year-Old Woman with MDD on Escitalopram

Stop the escitalopram immediately and conduct an urgent medical workup to identify reversible causes of delirium, as SSRIs—including escitalopram—can cause delirium with hallucinations in elderly patients, even when previously well-tolerated. 1

Immediate Actions: Rule Out Medical Causes First

Before attributing hallucinations to psychiatric causes, systematically investigate and treat reversible medical triggers that commonly precipitate delirium in older adults:

  • Check for infections immediately, particularly urinary tract infections and pneumonia, as these are the most common precipitating factors for acute mental status changes in elderly patients 2, 3
  • Assess for metabolic disturbances including hypoxia, dehydration, electrolyte abnormalities, and hyperglycemia 3
  • Evaluate for constipation and urinary retention, both of which significantly contribute to behavioral disturbances in patients who cannot verbally communicate discomfort 3
  • Review all medications for anticholinergic properties and potential drug interactions that worsen confusion and agitation 3
  • Assess pain systematically, as untreated pain is a major contributor to behavioral disturbances in elderly patients 3

The SSRI-Delirium Connection

Escitalopram can cause delirium with hallucinations in elderly patients, even when the medication was previously used without considerable side effects 1. This is a rare but documented complication:

  • Only five cases of delirium due to SSRIs as the primary etiologic factor have been published in the last two decades, but the phenomenon is real and clinically significant 1
  • SSRIs can cause delirium in aging patients even when previously well-tolerated, suggesting that age-related physiological changes may increase vulnerability 1
  • Escitalopram-induced delirium has been specifically documented in elderly patients, with hallucinations as a cardinal feature of the delirious state 1

Discontinuation Strategy

Taper escitalopram gradually over 5-7 days rather than stopping abruptly, as sudden discontinuation can itself precipitate delirium:

  • Fluoxetine discontinuation has been documented to cause delirium in a 65-year-old woman with MDD, with delirious pictures developing 2 days after stopping the medication 4
  • SSRI discontinuation syndrome symptoms may be attributable to rapid decrease in serotonin availability, and even long-half-life SSRIs can cause withdrawal symptoms in genetically vulnerable individuals 4
  • Reduce escitalopram from 10 mg to 5 mg for 3 days, then 2.5 mg for 2-3 days, then discontinue to minimize withdrawal risk while expediting removal of the potential causative agent

Pharmacological Management if Severe Agitation Develops

Reserve antipsychotics only for severe, dangerous agitation with imminent risk of harm after behavioral interventions have failed:

  • Use low-dose haloperidol (0.5-1 mg orally or subcutaneously) as first-line for acute severe agitation in elderly patients, with a strict maximum of 5 mg daily 3
  • Avoid benzodiazepines as first-line treatment except for alcohol or benzodiazepine withdrawal, as they increase delirium incidence and duration and cause paradoxical agitation in approximately 10% of elderly patients 3
  • All antipsychotics increase mortality risk 1.6-1.7 times higher than placebo in elderly patients with dementia, requiring discussion with the patient or surrogate decision maker before initiation 3

Non-Pharmacological Interventions

While conducting the medical workup and tapering escitalopram, implement these evidence-based environmental modifications:

  • Ensure adequate lighting and reduce excessive noise to minimize disorientation 3
  • Use calm tones, simple one-step commands, and gentle touch for reassurance rather than complex multi-step instructions 3
  • Provide frequent reorientation with easily visible calendars, clocks, and familiar objects from home 3
  • Maintain consistency of caregivers and minimize relocations to reduce confusion 3
  • Ensure at least 30 minutes of sunlight exposure daily and increase supervised mobility 3

Alternative Antidepressant Selection After Resolution

Once the delirium resolves and medical causes are treated, consider restarting antidepressant therapy with a different agent:

  • Bupropion may be a safer alternative as it has a different mechanism of action (noradrenergic/dopaminergic rather than serotonergic) and lower risk of delirium 2, 5
  • Start bupropion at 37.5 mg every morning in elderly patients, increasing by 37.5 mg every 3 days as tolerated, with a maximum of 150 mg twice daily 5
  • Screen for absolute contraindications to bupropion including seizure history, eating disorders, uncontrolled hypertension, and moderate to severe hepatic or renal impairment 5

Critical Monitoring Parameters

  • Evaluate daily with in-person examination to assess mental status, orientation, and presence of hallucinations 3
  • Monitor for extrapyramidal symptoms, falls, and orthostatic hypotension if antipsychotics are required 3
  • Reassess need for any psychotropic medication daily, with the goal of discontinuing as soon as the acute episode resolves 3

Common Pitfalls to Avoid

  • Do not assume hallucinations are purely psychiatric without ruling out medical causes—delirium is a medical emergency with twice the mortality if missed 2
  • Do not continue escitalopram while investigating if SSRI-induced delirium is suspected, as this delays resolution 1
  • Do not use multiple psychotropics simultaneously without first treating reversible medical causes 3
  • Do not restart the same SSRI after resolution—choose an alternative antidepressant with a different mechanism of action 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Aggressive Behavior in Geriatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is it safe to restart Lexapro (escitalopram) after symptoms of depression recur?
What is the safest first‑line antipsychotic to add for a 68‑year‑old woman with major depressive disorder with psychotic features who is currently taking escitalopram (Lexapro)?
What is the preferred choice between escitalopram and amitriptyline for the treatment of major depressive disorder?
What is the next step in managing a 40-year-old female patient's treatment with Lexapro (escitalopram) 10mg and Adderall ER (dextroamphetamine/amphetamine) 10mg for depression, anxiety, and Attention Deficit Hyperactivity Disorder (ADHD)?
Is it safe to take 25 mg of Lexapro (escitalopram)?
At what age can azelastine nasal spray be initiated for allergic rhinitis in children?
How should I manage a 50‑year‑old female with a history of aortic valve replacement for aortic stenosis and hypertrophic cardiomyopathy who has persistent depression and anxiety despite trials of multiple selective serotonin reuptake inhibitors (fluoxetine, escitalopram, sertraline, paroxetine) and bupropion, and who is currently taking clonazepam (Klonopin) 0.5 mg twice daily as needed for anxiety and oxycodone for neck pain?
How should an asymptomatic non‑ossifying fibroma ≤5 cm in a child or adolescent be managed?
Can anorexia nervosa cause pericardial effusion?
In a patient with sepsis and elevated fibrinogen, how should the fibrinogen level and overall management be addressed?
What is the incidence of bilateral versus unilateral non‑ossifying fibroma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.